Short-Term Folate Supplementation in Physiological Doses Has No Effect on ESR1 and MLH1 Methylation in Colonic Mucosa of Individuals with Adenoma
Author(s) -
Reyad Abbadi,
Peter W. Emery,
Maria Pufulete
Publication year - 2012
Publication title -
lifestyle genomics
Language(s) - English
Resource type - Journals
eISSN - 2504-3188
pISSN - 2504-3161
DOI - 10.1159/000345819
Subject(s) - methylenetetrahydrofolate reductase , medicine , methylation , placebo , mlh1 , endocrinology , dna methylation , homocysteine , colorectal cancer , colorectal adenoma , chemistry , cancer , genotype , pathology , biochemistry , gene expression , alternative medicine , dna mismatch repair , gene
Low folate intake may increase risk of colorectal cancer by altering gene-specific methylation in the colon. We determined whether supplementation with physiological doses of folate could alter methylation in the oestrogen receptor 1 (ESR1) and mutL homolog 1 (MLH1) genes in colonic mucosa of subjects with colorectal adenoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom